Stay updated with breaking news from Replication Combing Assay. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The event highlighted the rising importance of artificial intelligence (AI) and machine learning (ML) in drug discovery.Genomic Vision actively engaged in networking, fostering new customers interested in GV technology and its applications in general.Genomic Vision's Replication Combing Assay (RCA) aligns with evolv...
Genomic Vision Announces Early Access Program for a New Detection Suite Based on Innovative Artificial Intelligence Technology Genomic Vision (the "Company" FR0011799907 GV), a biotechnology company that develops tools and services dedicated to the analysis and control of changes in the genome, today announced that it has initiated an early access program for FiberSmart, a new suite to automate the detection and quantification of fluorescent signals on combed DNA. Through innovations in imaging, machine learning and Artificial Intelligence (AI), FiberSmart significantly enhances the automated...